Start an analysis for AVD
American Vanguard Corporation
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $15m | 31-Dec-25 | 10-K filed 30-Sep-26 |
| Remaining authorization | $15mEST | 31-Dec-25 | 10-K filed 30-Sep-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | Not found in filings | — | |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 25-May-23 | $15m | $15mEST | n/a | On May 25, 2023, pursuant to a Board of Directors resolution, the Company announced its intention to repurchase up to $15,000 of its common stock under a 10b5-1 plan, par value $0.10 per share, in the open market over the succeeding one year10-K filed 30-Sep-26 |
Open-market repurchases
None reported in the filings we hold.